Optimization of Atenolol Core Tablet CHAPTER 5: OPTIMIZATION OF FORMULATION OF ATENOLOL CORE TABLETS

Size: px
Start display at page:

Download "Optimization of Atenolol Core Tablet CHAPTER 5: OPTIMIZATION OF FORMULATION OF ATENOLOL CORE TABLETS"

Transcription

1 CHAPTER 5: OPTIMIZATION OF FORMULATION OF ATENOLOL CORE TABLETS 5.1. AIM OF THE STUDY The pulsatile type press coated colon targeted atenolol tablet release drug after 6 hr lag time. The compression coated tablet has two parts, internal core tablet and surrounding coat. For the preparation of pulsatile type press coated tablet of atenolol, first step is to prepare fast disintegrating core tablet of atenolol, which release drug within a shorter period of time after a lag time. Fast disintegrating tablets were prepared by addition of superdisintegrant. The aim of this study is to optimize the formulation of core tablets of atenolol, which give faster rate of drug release. So, the optimized core tablets of atenolol are used for preparation of press coated pulsatile tablets STATISTICAL OPTIMIZATION OF FORMULATION OF ATENOLOL CORE TABLETS A 3 2 randomized full factorial design and optimization process was investigated to find the utility in the optimization of formulation of core tablets of atenolol. In this design, two factors were evaluated, each at three levels, and experimental trials were performed at all nine possible combinations. This design is suitable for exploring linear response surface and constructing polynomial model incorporating polynomial terms used to evaluate the response. Y = b0 + b1a+b2b.... (1) Where, Y is the dependent variables, b0 is the arithmetic mean response of the nine runs, b1 is the estimated coefficient for the factor A and b2 is the estimated coefficient for the factor B. The main effects (A and B) represent the average result of changing one factor at a time from its low to high value. The amount of superdisintegrant (A) and amount of dry binder (B) in core formulation were selected as independent variables. The times required for 85% (T85%) drug Rajesh A. Keraliya 107

2 dissolution were selected as dependent variable. The independent variables with their levels are described in the table 11, while experimental design with corresponding formulation outline in table 12. Table 11: Independent variables with their levels Independent Variable Levels Low Medium High A: Sodium starch glycolate (mg) B: Amount of polyvinyl pyrrolidone (mg) Table 12 described the formulations prepared for 3 2 randomized full factorial design to optimize the formulation of core tablets of atenolol with the following goals: (1) Amount of SSG : 2.5 to 7.5 mg (2) Amount of PVP K30: 5 to 15 mg (3) T85% = 2 min Table 12: Formulation design layout for 3 2 factorial design Formulation code Independent variables coded value Independent variables actual value Factor 1 (A) Factor 2 (B) Factor 1 (A) Factor 2 (B) AT AT AT AT AT AT AT AT AT Where, A = Amount of sodium starch glycolate (mg) and B = Amount of polyvinyl pyrrolidone (mg) Rajesh A. Keraliya 108

3 5.3. PREPARATION OF ATENOLOL CORE TABLETS The core tablets of atenolol were prepared by direct compression method. Atenolol core tablet was formulated using various amount of polyvinyl pyrrolidone (PVP K30) as dry binder and sodium starch glycolate as superdisintegrant as describe in table 13. An accurately weighed quantity of atenolol, microcrystalline cellulose, polyvinyl pyrroloide (PVP K30) and sodium starch glycolate pass through 40# and mix in double cone blender for 15 min. Add talc (2% w/w) (40#) into blend and mix in double cone blender for 10 min. Add magnesium stearate (1% w/w) (40#) into blend and mix in double cone blender for 5 min. The resultant powder mixtures were compressed into tablets (average tablet weight = 80 mg) by 6 mm standard concave plain punches using rotary tabletting machine (Hardik Engineering Works, Ahmedabad, India). The prepared atenolol core tablets were tested for weight variation, hardness, thickness, drug content, disintegration time, friability and in vitro dissolution study (Sawada et al., 2003, Mayur et al., 2009, Gang et al., 2004). Table 13: Formulations of atenolol core tablets Ingredients (mg) AT1 AT2 AT3 AT4 AT5 AT6 AT7 AT8 AT9 Atenolol Sodium Starch glycolate (SSG) Polyvinyl pyrrolidone (PVP K30) Microcrystalline cellulose (MCC) Talc Mg stearate Total wt EVALUATION OF ATENOLOL CORE TABLETS Spectrophotometric estimation of atenolol Atenolol was estimated by UV visible spectroscopy. Spectrophotometric estimation of atenolol was carried out in triplicates methanol and phosphate buffer ph 7.4. Rajesh A. Keraliya 109

4 Preparation of standard stock solution in methanol and phosphate buffer ph 7.4 Accurately weighed 100 mg of atenolol was placed in 100 ml volumetric flask and dissolved in 100 ml of methanol and phosphate buffer ph 7.4. From this solution, 10 ml solution was withdrawn and further diluted to 100 ml with methanol and phosphate buffer ph 7.4 to yield the standard stock solution of atenolol (100 µg/ml). Construction of calibration curve in methanol and phosphate buffer ph 7.4 From the stock solution, 5, 10, 15, 20, 25 and 30 ml were withdrawn and diluted to 100 ml with methanol to yield concentration of 5, 10, 15, 20, 25 and 30 g/ml respectively. For phosphate buffer ph 7.4, 2.5, 5, 10, 15, 20, 25, 30 and 35 ml of stock solution were withdrawn and dilute to 100 ml with phosphate buffer ph 7.4 to yield concentration of 2.5, 5, 10, 15, 20, 25, 30 and 35 g/ml respectively. Absorbance of each solution was measured at 225 nm using UV visible spectrophotometer (Thermo Scientific Evolution 201). Samples were analyzed in triplicate and the average values were used for plotting the graph of absorbance versus concentration ( g/ml). Regression analysis was done on each beer s plot using Microsoft excel Drug-Excipient compatibility study Fourier transform infrared spectroscopy The FTIR spectra of pure sample powder of atenolol and powder of atenolol core tablet were recorded on a FT-IR spectrophotometer (Shimadzu, FTIR-8400S), in the wavelength region of cm -1. Samples (about 1% w/w) were mixed with KBr powder and suitable amount of sample was placed in sample holder. The sample holder was placed in the light path and the spectrum was obtained. Differential Scanning Calorimetry (DSC) A differential scanning calorimeter (DSC-60, shimadzu corporation, Japan) was used to monitor the thermal events during heating. The DSC was calibrated by the melting points of indium (156.6±0.2 0 C) and zinc (419.5±0.3 0 C) standards. Samples of pure sample powder of atenolol and powder of atenolol core tablet weighing 2 3 mg were placed in open aluminium pans and heated from 50 to C at a rate of 20 0 C per min. Nitrogen Rajesh A. Keraliya 110

5 was used as a purge gas at a flux rate of 50 ml/min. The onsets of the melting points were calculated by the software (Pyris, Perkin-Elmer) Evaluation of flow property of powder blend Angle of Response For characterizing the flowability, the angle of response was determined by pouring the powder blend used for preparation of atenolol core tablets and atenolol press coated tablets through a funnel. Height (h) and radius (r) of the powder cone were measured to calculate the angle of response as tan α = h/r. A small value for represents a good flowing powder. Carr s Consolidation Index a) Bulk Density The bulk density, as a measure used to describe packing of powder, was determined by transferring the accurately weighed sample of powder mixture to a graduated cylinder with the aid of a funnel. The initial volume was noted. Ratio of weight of the sample to the volume it occupied was calculated. Bulk Density = Mass of powder / Bulk volume.(2) b) Tapped Density Weighed sample of powder mixture was transferred to a graduated cylinder and was tapped for a fixed time or for a fixed number of taps (100). The tapped density was determined by using the following formula: Tapped Density = Mass of powder / Tapped volume.(3) Based on the apparent bulk density and the tapped density, the percentage compressibility of the powder mixture was determined by the following formula. Carr s index = {(Tapped density- Bulk density) / Tapped density}* 100 (4) Hausner s Ratio Hausner ratio is an indirect index of ease of measuring the powder flow. It was calculated by the following formula: Rajesh A. Keraliya 111

6 Hausner s ratio = Tapped density / Bulk density. (5) Post compression evaluation of atenolol core tablets Weight Variation Twenty tablets from each batch were individually weighed using electronic digital balance (Shimadzu BL 220 H) and average weight was calculated. Individual weights of the tablets were compared with the average weight according to the official method in Indian Pharmacopoeia, 2007 (Fukui et al., 2000, Gazzaniga et al., 1994). Hardness Six tablets from each batch were selected and tested for tablet hardness using Monsanto hardness tester. The tablet was placed in contact between the plungers and the handle was pressed, the force of the fracture that causes the tablet to break was recorded (Krishnaiah et al., 1998). Thickness The thickness of ten tablets from each batch was determined using vernier calipers as per Indian Pharmacopoeia, 2007 (Madhusudan and Vishal, 2001). Friability The friability of the twenty tablets from each batch was determined using Roche friabilator (Indosati Scientific Lab. Equipments) (Mastiholimath et al., 2007, Matsuo et al., 1995). This device subjects the tablets to the combined effect of abrasions and shock in a plastic chamber revolving at 25 rpm and dropping the tablets at a height of 6 inches in each revolution. A pre-weighed sample (20 tablets) was placed in the friabilator and is subjected to 100 revolutions. Tablets were dedusted and reweighed. The % friability (F) was calculated using following formula: F = (W1-W2 / W1) (6) Where, W1 is the initial weight of the sample of twenty tablets before the test W2 is the weight of the tablet after the test Rajesh A. Keraliya 112

7 Disintegration test Six tablets of each batch were placed in the each glass tube of disintegration test apparatus (Indosati Scientific Lab. Equipments) containing 900 ml of water maintained at a temperature of 37±1 0 C and disintegration time of core tablets was determined (Shweta et al., 2008, Gazzaniga et al., 2006). The study was carried out in triplicates. Drug content For determination of drug content, ten tablets were crushed into powder and powder equivalent to 45 mg of atenolol was weighed and dissolved in methanol then filtered through syringe filter (Axiva SFCA25X, 0.45µm). Solution was analyzed for Atenolol content by spectrophotometrically by UV spectrophotometer (Thermo Scientific Evolution 201) at wavelength of 225 nm using methanol as blank (Swati et al., 2010). Wetting time To measure wetting time of tablet, a piece of tissue paper was folded twice and placed in a small petridish of 8.5 cm diameter. 10 ml of distilled water containing methylene blue, a water soluble dye, is added to petridish. A tablet was kept on the paper and the time required for water to reach upper surface of the tablet at room temperature is noted as a wetting time (Kalpesh et al., 2011). The study was carried out in triplicates. Water absorption ratio A piece of tissue paper folded twice was placed in a small petridish of 8.5 cm diameter containing 6 ml of distilled water. A tablet was put on the paper and the time required for complete wetting of the tablet was measured. The wetting tablet was then weighed. Water absorption ratio R was determined using the equation (Bhupendra and Dipesh, 2010): Water absorption ratio (R) = (W2 W1)/ W1 *100.(7) Where, W1 = weight of tablet before water absorption and W2 = weight of tablet after water absorption. In vitro drug release study of atenolol core tablets In vitro dissolution studies of atenolol core tablets were carried out using USP Type II dissolution apparatus (Electrolab, TDT-08L) using 900 ml of phosphate buffer ph 7.4 as Rajesh A. Keraliya 113

8 a dissolution media at a temperature of 37±1 0 C at 75 rpm. At regular time intervals, 10 ml of sample was withdrawn and same amount replaced by fresh medium. Samples were suitably diluted and filtered through syringe filter (Axiva SFCA25X, 0.45µm). Drug amount released was analyzed spectrophotometrically by UV spectrophotometer (Thermo Scientific Evolution 201) at wavelength of 225 nm. All studies were carried out in triplicates (Swati et al., 2010). The study was carried out in triplicates Stability study The optimized formulations of atenolol core tablets were subjected for accelerated stability studies according to ICH guidelines (40 ± 2 0 C and 75 ± 5% RH) for a period of 6 months in a stability chamber. The optimized formulations of atenolol core tablets were placed in vials and hermetically closed with bromobutyl rubber plugs, sealed with aluminum caps and placed in stability chamber. The samples were withdrawn at initial, 1, 2, 3 and 6 month and evaluated for the drug content, hardness, disintegration time and in vitro dissolution. The study was carried out in triplicates RESULTS AND DISCUSSION Spectrophotometric estimation of Atenolol Spectrophotometric estimation of Atenolol in methanol Table 14: Spectrophotometric analysis of atenolol in methanol Conc. Absorbance Average Standard (µg/ml) Set 1 Set 2 Set 3 Absorbance Deviation Rajesh A. Keraliya 114

9 Average Abs. Ph.D Thesis Atenolol exhibited its maximum absorption at 225 nm and obeyed Beer s law in the range of μg/ml. Linear regression of absorbance on concentration gave equation y = 0.024x with a correlation coefficient of So, calibration curve of atenolol in methanol showed in figure 27 was linear in concentration range of μg/ml Calibration curve of atenolol methanol y = 0.024x R² = Conc. (µg/ml) Figure 27: Calibration curve of atenolol in methanol Figure 28: Spectrophotometric images showing λmax of atenolol in methanol Rajesh A. Keraliya 115

10 Average Abs. Ph.D Thesis Spectrophotometric estimation of atenolol in Phosphate buffer ph 7.4 Table 15: Spectrophotometric analysis of atenolol in phosphate buffer ph 7.4 Conc. Absorbance Average Standard (µg/ml) Set 1 Set 2 Set 3 Absorbance Deviation Atenolol exhibited its maximum absorption at 225 nm and obeyed Beer s law in the range of μg/ml. Linear regression of absorbance on concentration gave equation y = 0.023x with a correlation coefficient of So, calibration curve of atenolol in phosphate buffer ph 7.4 showed in figure 29 was linear in concentration range of μg/ml. Calibration curve of atenolol in phosphate buffer ph y = x R² = Conc. (µg/ml) Figure 29: Calibration curve of atenolol in phosphate buffer ph 7.4 Rajesh A. Keraliya 116

11 Figure 30: Spectrophotometric image showing λmax of atenolol in phosphate buffer ph Drug-Excipient compatibility study Fourier transform infrared spectroscopy Fourier transform infrared spectroscopy was used to analyze of pure sample powder of atenolol and powder of atenolol core tablet. Figure 31 showed that FTIR spectras of all samples were identical and the main absorption bands of atenolol appeared in all the spectra. Absorption band for N-H stretching of CO-NH2 group of atenolol appeared around 3340 and 3160 cm 1 in the both spectra. The absorption band for -C=O (amide I) and N-C=O (amide II) stretching of atenolol located at 1625 cm 1 and 1500 cm 1 in spectra of pure atenolol drug powder, and these were also appear and not shifted in the FTIR spectra of powder of atenolol core tablet. All spectra showed =C-H stretching of alkane group of atenolol around 2940 cm 1. Similarly, the H2N-C=O stretching of atenolol located at 1400 cm 1 was appeared both in both spectra. Isopropyl group of atenolol showed a sharp peak in all spectra around 1385 cm 1 and 1170 cm 1. Arylether of atenolol structure give the peak at 1390 cm 1 and 1235 cm 1 in spectra of pure atenolol drug powder, and these were also appear in the FTIR spectra of powder of atenolol core tablet (Klaus et al., 2005). The FTIR spectra of the tested samples showed Rajesh A. Keraliya 117

12 the prominent characterizing peaks of pure atenolol which confirmed that no chemical modification of the drug had been taken place and indicated that there is no chemical interaction occurred between drug and excipients at the molecular level. Figure 31: FTIR spectra of: pure sample powder of atenolol (A) and powder of atenolol core tablet (B) Differential Scanning Calorimetry (DSC) DSC thermographs of pure sample powder of atenolol and powder of atenolol core tablet showed a sharp exothermic peak (Tm) at C and C respectively, which corresponding to melting point of atenolol (154 C to 156 C) (Klaus et al., 2005, Gurpreet et al., 2009). Melting exotherm not appreciably change in powder of atenolol core tablet as compared to atenolol pure sample. This observation confirmed the absence of chemical interaction of drug with excipients of core tablet, further supporting the results of IR spectroscopy. The DSC results of pure sample powder of atenolol and powder of atenolol core tablet showed in figure 32. Rajesh A. Keraliya 118

13 Figure 32: DSC thermographs of: pure sample powder of atenolol (A) and powder of atenolol core tablet (B) Flow property study of powder blend The angle of repose, hausner s ratio and carr s index of powder blend used for atenolol core tablets were ranged from O ± 0.65 to O ± 0.50, ± 0.13 to ± 0.14, and ± 0.41 % to ± 0.44 % respectively as shown in table 16. The results of indicated that powder blend has good flow property with good compressibility and suitable for direct compression method Post compression evaluation of atenolol core tablets As shown in table 17 all atenolol core tablets had good mechanical strength, showed hardness in range from 3.0 to 4.5 Kg/cm 2 and friability was range from 0.05 ± 0.05 to 0.17 ± Friability is less than 1% which indicated that tablets had good mechanical resistance. All atenolol core tablets showed drug content above %. In weight Rajesh A. Keraliya 119

14 variation test, none of tablets showed more than 10 % weight variation from average weight. So, all formulations pass the weight variation test as per IP. Tablet thickness varied from 3.19 to 3.20 mm. Table 16: Flow property study for powder blend of atenolol core tablets Formulation Code Bulk Density (g/cm 3 ) (Avg. ± SD) Tapped Density (g/cm 3 ) (Avg. ± SD) Carr s Index (%) (Avg. ± SD) Hausner s Ratio (HR) (Avg. ± SD) Angle of Repose (Ɵ) (Avg. ± SD) AT ± ± ± ± O ± 0.25 AT ± ± ± ± O ± 0.40 AT ± ± ± ± O ± 0.50 AT ± ± ± ± O ± 0.36 AT ± ± ± ± O ± 0.55 AT ± ± ± ± O ± 0.35 AT ± ± ± ± O ± 0.65 AT ± ± ± ± O ± 0.47 AT ± ± ± ± O ± 0.34 Table 17: Post compression parameters of atenolol core tablets Formulation Code Hardness (Kg/cm 2 ) (Avg. ± SD) Friability (%) (Avg. ± SD) Drug content (%) (Avg. ± SD) Weight variation (mg) (Avg. ± SD) Tablet Thickness (mm) (Avg. ± SD) AT ± ± ± ± ± 0.06 AT ± ± ± ± ± 0.05 AT3 3.0 ± ± ± ± ± 0.01 AT ± ± ± ± ± 0.03 AT5 3.5 ± ± ± ± ± 0.05 AT ± ± ± ± ± 0.03 AT7 4.5 ± ± ± ± ± 0.04 AT ± ± ± ± ± 0.05 AT ± ± ± ± ± 0.02 Rajesh A. Keraliya 120

15 Superdisintegrants are added to oral solid dosage formulations to facilitate disintegration. Commonly used superdisintegrants such as crospovidone, croscarmellose sodium, and sodium starch glycolate are highly efficient at low concentration levels in the tablet formulation at facilitating the rate and extent of tablet disintegration. After completion of disintegration study, it was found that tablets prepared with sodium starch glycolate, disintegrate by rapid uptake of water, followed by rapid and enormous swelling. From table 18, formulation with 7.5 mg sodium starch glycolate showed a remarkable increase in disintegration time as compared to formulation containing 2.5 and 5 mg SSG. It was observed that sodium starch glycolate is effective at 5%. Disintegration time of tablets decreased from 39 second to 28 second as the amount of SSG was increased from 2.5 mg to 5 mg respectively in AT1 and AT2 formulation. While, the increase of the amount of sodium starch glycolate from 5 mg to 7.5 mg, the disintegration time was decreased as shown in table 18. The mechanism of disintegration of sodium starch glycolate is swelling. In the beginning it swells very fast and later on it swells gradually, probably due to confinement of the tablet and also due to viscosity change of the penetrating liquid. This exceptional behavior could also be due to the higher concentration of sodium starch glycolate which may act as a binder instead of swelling which causes gelling. Thus, causing a viscous barrier and so the disintegration time increases (Swati et al., 2010, Mallikarjuna et al., 2008). These results also supported by the water absorption study. The water uptake by the tablet is facilitated by the sodium starch glycolate, while the tablet disintegration is facilitated by the swelling force exhibited by sodium starch glycolate at their optimum concentration (Bhupendra and Dipesh, 2010). So, as the amount of sodium starch glycolate increased, the water absorption ratio increased up to optimum level of 5 mg SSG. But, at high amount 7.5 mg of SSG, water absorption ratio decreased, this may be due to at the higher concentration of sodium starch glycolate which may act as a binder instead of swelling. Formulations AT1, AT2 and AT3 showed ± 3.85, ± 4.57 and ± 5.85 water absorption ratio respectively. Wetting was closely related to the inner structure of the tablets and the hydrophilicity of the excipients. SSG shows its disintegrant effect by the mechanism of swelling (Shailendra et al., 2009). It is interesting to note that wetting times decreased with increase in the level of sodium starch glycolate from 2.5 mg to 5 mg in the tablets. It was observed that formulations AT2 showed lower wetting time 20 sec., while AT1 showed wetting time 31 Rajesh A. Keraliya 121

16 sec. But formulations with higher level of sodium starch glycolate (7.5 mg), showed high wetting time. AT3, AT6 and AT9 containing high level of sodium starch glycolate had higher water absorption ratio and take more time for wetting of tablets (Table 18). When higher percentage of PVP K30 was used, higher binding between granules is expected in the tablets and tablet became harder, so, an increase in the amount of PVP K30 in the formulation lead to increase in hardness, disintegration time, wetting time, and decrease water absorption ratio and friability as shown in table 17 and 18 (Vineet et al., 2010). Table 18: Disintegration time, wetting time, wetting ratio and T85% of AT tablets Formulation Disintegration Wetting time Water T85% (min.) Code Time (Sec.) (Sec.) absorption ratio AT1 39 ± ± ± ± 0.5 AT2 28 ± ± ± ± 1.0 AT3 38 ± ± ± ± 1.5 AT4 154 ± ± ± ± 2.5 AT5 93 ± ± ± ± 4.0 AT6 122 ± ± ± ± 3.5 AT7 497 ± ± ± ± 4.5 AT8 426 ± ± ± ± 3.0 AT9 476 ± ± ± ± 4.0 Dissolution study of atenolol core tablets as showed in figure 33. In vitro dissolution study indicated that as the amount of sodium starch glycolate increased upto optimum level (5 mg), the rate of drug release increased due to faster disintegration of tablets. But, as the amount of sodium starch glycolate increased beyond the 5 mg, the rate of drug release was decreased, because sodium starch glycolate might have formed a thick barrier to the further penetration of the disintegration medium and hindered the disintegration or leakage of tablet contents (Kalpesh et al., 2011). The AT2 formulation containing 5 mg of sodium starch glycolate showed higher rate of drug release and least 2 ± 1.0 min T85%. So, AT2 formulation showed optimum performance. Rajesh A. Keraliya 122

17 % Cumulative Drug Release Ph.D Thesis 120 Drug release study of Atenolol core tablets Time (min.) A1 A2 A3 A4 A5 A6 A7 A8 A9 Figure 33: Dissolution profile of atenolol core tablets Statistical analysis for optimization of formulation of atenolol core tablets Linear model used to check effect of individual two factors on response in polynomial equation, while, quadratic model used to check effect of individual two factors on response in polynomial equation plus to check effect of square of individual two factors on response in polynomial equation. But by default, DOE suggested linear model according to data. A 3 2 factorial design was adopted; the response values subjected for this analysis were T85%. Table 19 showed that values of response T85% for the AT1 to AT9 formulations containing different amount of SSG and PVP K30. It was logically decided to obtain minimum T85% from the formulated products. The results for T85%, a dependent variables of the batches are shown in table 19 and equation 8 and 9 represent the polynomial equations in terms of coded factors and actual factors respectively. Polynomial equation in terms of coded factors T85% = *A * B. (8) Polynomial equation in terms of coded factors T85% = *SSG * PVP. (9) Rajesh A. Keraliya 123

18 Table 19: Results of T85% for atenolol core tablets Formulation code Independent variables coded value Independent variables actual value Dependent variable Amount of Amount of Amount of Amount of SSG (mg) PVP (mg) SSG (mg) PVP (mg) (A) (B) (A) (B) T85% (Y) (min.) AT AT AT AT AT AT AT AT AT A coefficient with a positive sign shows a synergistic effect whereas a coefficient with a negative sign shows an antagonistic effect. In equation 8, A coefficient of Independent factor A with a negative sign ( 2.64 *A) indicates on increased the amount of SSG, T85% decreased (as shown in table 19, formulation AT1 & AT2, AT4 & AT5, and AT7 & AT8). T85% decreased from 5 min to 2 min as the SSG level in AT2 formulation is increased to 5 mg from 2.5 mg of AT1 formulation. Whereas, a coefficient of Independent factor B with a positive sign ( * B) indicated T85% increased as the amount of PVP K30 increased (In table 19, Formulation AT1 to AT9). T85% increased from 2 min to 25 min as the PVP K30 level in AT5 formulation is increased to 10 mg from 5 mg of AT2 formulation. Analysis of variance (ANOVA) study for response surface linear model showed the p-value of model is which is less than indicated model terms are significant and value of correlation coefficient is (R 2 ) which indicated that a goodness of fit of model. The polynomial Equation can be used to draw conclusions after considering the magnitude of coefficient and the mathematical sign it carries, (i.e. positive or negative). Rajesh A. Keraliya 124

19 Figures 34 and 35 describe the effect of independent variables on response T85%. One factor plot showed in figure 34 indicated that as the amount of SSG increased from low to medium level, T85% decreased as the formulation disintegrated quickly, on increased the amount of SSG due to swelling of SSG lead to rapid disintegration of core tablets, but, as the amount of SSG increased from medium to high level, T85% increased due to formation of a viscous gel layer by sodium starch glycolate which prevent the penetration of the disintegration medium (Bolhuis et al., 1997). While, as the amount of PVP K30 increased, T85% also increased because of PVP K30 bind the particles together and form harder tablet. So, when amount of PVP K30 increased, disintegration time of tablets also increased (figure 35). Result suggested that the presence of SSG and PVP K30 were essential for achieving desired T85%. Design-Expert Software Factor Coding: Actual T85 (min) Design Points 95% CI Bands X1 = A: SSG Actual Factor B: PVP = One Factor T 8 5 (m in ) A: SSG (mg) Figure 34: Effect of amount of SSG on T85% The relationship between the dependent and independent variables was further elucidated using contour plots (figure 36) and 3-D response plot (figure 37). Logically, it was predecided to obtain the minimum T85% (T85% = 5 min.) for the formulated products. The results for dependent variables T85% of the batches are shown in table 19. In contour plot and 3-D response plot showed that only formulation AT2 had T85% near to desired T85% (figure 36 & 37, indicated by light blue). Rajesh A. Keraliya 125

20 Design-Expert Software Factor Coding: Actual T85 (min) Design Points 95% CI Bands X1 = B: PVP Actual Factor A: SSG = One Factor T 8 5 (m in ) B: PVP (mg) Figure 35: Effect of amount of PVP K30 on T85% Design-Expert Software Factor Coding: Actual T85 (min) Design Points T85 (min) X1 = B: PVP X2 = A: SSG A : S S G (m g ) B: PVP (mg) Figure 36: Contour plot showing the effect of SSG and PVP K30 on T85% Optimization of result For the optimization of atneolol core tablet formulation, constraints were fixed for all factors and response. Constraints were set according to formulation of atenolol core tablet using minimum amount of excipients, which would give desired response. In the present Rajesh A. Keraliya 126

21 study, T85% was predecided 2 min. In overlay plot for optimization, data presented in white box was obtained when desirability value 1.0 was got and desirability value 1.0 or near to 1.0 indicated optimum formulation. Overlay plot indicated that 4.56 mg of SSG and 5.76 mg of PVP K30 containing atenolol core tablet achieved desired near to 2 min T85% (figure 38). Validation of optimization technique was done by preparing checkpoint batch and responses were evaluated. The response value observed in the checkpoint batch was closet to theoretical value obtained from polynomial equation. Design-Expert Software Factor Coding: Actual T85 (min) Design points above predicted value Design points below predicted value X1 = B: PVP X2 = A: SSG T 8 5 (m in ) A: SSG (mg) B: PVP (mg) Figure 37: 3-D response plot showing the effect of SSG and PVP K30 on T85% Design-Expert Software Factor Coding: Actual Overlay Plot Overlay Plot T85 Design Points X1 = A: Amount of SSG X2 = B: Amount of PVP B : A m o u n t o f P V P (m g ) T85: X X T85: A: Amount of SSG (mg) Figure 38: Overlay plot for optimization of atenolol core tablet formulation Rajesh A. Keraliya 127

22 Stability study The optimized AT2 batch of atenolol core tablets were subjected for accelerated stability studies according to ICH guidelines (40 ± 2 0 C and 75 ± 5% RH) for a period of 6 months in a stability chamber. Formulations did not show any significant changes in the drug content, hardness, disintegration time and in vitro dissolution during stability study as shown in table 20. Hence, the AT2 atenolol core tablets were sufficiently stable as per regulatory requirements. Table 20: Stability study of optimized atenolol core tablets Tests Initial 1 month 2 months 3 months 6 months Drug content (%) ± ± ± ± ± 1.52 (Avg. ± SD) Hardness 3.25 ± ± ± ± ± 0.25 (kg/cm 2 ) Disintegration 28 ± ± ± ± ± 1.40 time (sec.) T85% (min.) 2 ± ± ± ± ± 1.45 CONCLUSION The fast disintegrating core tablet of atenolol were prepared using different amount of superdisintegrant (SSG) and dry binder (PVP K30). Atenolol core AT2 tablet containing 5 mg of SSG and 5 mg of PVP K30 showed good hardness and faster disintegration. Fast disintegration of core tablet requires in press coated pulsatile release tablets to achieve burst release after lag time. So, optimized atenolol core AT2 tablet, used for preparation of press coated pulsatile formulation of atenolol in further studies. Rajesh A. Keraliya 128

CHAPTER VI FACTORIAL STUDIES ON THE EFFECTS OF CYCLODEXTRINS AND SOLUTOL HS15 ON THE SOLUBILITY AND DISSOLUTION RATE OF EFAVIRENZ AND RITONAVIR

CHAPTER VI FACTORIAL STUDIES ON THE EFFECTS OF CYCLODEXTRINS AND SOLUTOL HS15 ON THE SOLUBILITY AND DISSOLUTION RATE OF EFAVIRENZ AND RITONAVIR CHAPTER VI FACTORIAL STUDIES ON THE EFFECTS OF CYCLODEXTRINS AND SOLUTOL HS15 ON THE SOLUBILITY AND DISSOLUTION RATE OF EFAVIRENZ AND RITONAVIR Efavirenz and ritonavir, two widely prescribed anti retroviral

More information

Formulation and evaluation of immediate release salbutamol sulphate

Formulation and evaluation of immediate release salbutamol sulphate 5 Formulation, optimization and evaluation of immediate release layer of salbutamol sulphate Salbutamol is moderately selective beta (2)-receptor agonist similar in structure to terbutaline and widely

More information

Formulation and Evaluation

Formulation and Evaluation Chapter-5 Formulation and Evaluation 5.1 OBJECTIVE After successful taste masking and solubility enhancement of drugs in preliminary studies, by using Mannitol Solid Dispersion, next step includes the

More information

FORMULATION AND EVALUATION OF PIROXICAM AND CELECOXIB TABLETS EMPLOYING PROSOLVE BY DIRECT COMPRESSION METHOD

FORMULATION AND EVALUATION OF PIROXICAM AND CELECOXIB TABLETS EMPLOYING PROSOLVE BY DIRECT COMPRESSION METHOD Int. J. Chem. Sci.: 6(3), 2008, 1270-1275 FORMULATION AND EVALUATION OF PIROXICAM AND CELECOXIB TABLETS EMPLOYING PROSOLVE BY DIRECT COMPRESSION METHOD K. P. R. CHOWDARY, P. TRIPURA SUNDARI and K. SURYA

More information

STUDIES ON EFFECT OF BINDERS ON ETORICOXIB TABLET FORMULATIONS

STUDIES ON EFFECT OF BINDERS ON ETORICOXIB TABLET FORMULATIONS Int. J. Chem. Sci.: 10(4), 2012, 1934-1942 ISSN 0972-768X www.sadgurupublications.com STUDIES ON EFFECT OF BINDERS ON ETORICOXIB TABLET FORMULATIONS K. VENUGOPAL * and K. P. R. CHOWDARY a Nirmala College

More information

STABILITY STUDIES OF FORMULATED CONTROLLED RELEASE ACECLOFENAC TABLETS

STABILITY STUDIES OF FORMULATED CONTROLLED RELEASE ACECLOFENAC TABLETS Int. J. Chem. Sci.: 8(1), 2010, 405-414 STABILITY STUDIES OF FORMULATED CONTROLLED RELEASE ACECLOFENAC TABLETS V. L. NARASAIAH, T. KARTHIK KUMAR, D. SRINIVAS, K. SOWMYA, P. L. PRAVALLIKA and Sk. Md. MOBEEN

More information

Journal of Global Trends in Pharmaceutical Sciences Vol.2, Issue 4, pp , Oct -Dec 2011

Journal of Global Trends in Pharmaceutical Sciences Vol.2, Issue 4, pp , Oct -Dec 2011 ISSN: 223-7346 Research Article Journal of Global Trends in Pharmaceutical Sciences Vol.2, Issue 4, pp -394-43, Oct -Dec 211 FORMULATION AND INVITRO EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF GLIMEPIRIDE

More information

Formulation and evaluation of oro-dispersible tablets of lafutidine

Formulation and evaluation of oro-dispersible tablets of lafutidine Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2015, 7 (5):226-235 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4

More information

Formulation and In-vitro Evaluation of Chewable Tablets of Montelukast Sodium

Formulation and In-vitro Evaluation of Chewable Tablets of Montelukast Sodium Available online on www.ijddt.com International Journal of Drug Delivery Technology 214; (3); 98-13 Research Article ISSN: 97 441 Formulation and In-vitro Evaluation of Chewable Tablets of Montelukast

More information

INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND CHEMICAL SCIENCES

INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND CHEMICAL SCIENCES Research Article Formulation, Development and Evaluation of Fast Dissolving Tablet of Salbutamol Sulphate by Using Superdisintegrants of Various Concentrations Santosh K 1 *, Meenakshi B 2 and Jyoti M

More information

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY ISSN Research Article

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY  ISSN Research Article INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 8407 Research Article FORMULATION AND EVALUATION OF IMMEDIATE RELEASE VENLAFAXINE HCL TABLETS: COMPARATIVE STUDY OF SUPER DISINTEGRANT

More information

Formulation and evaluation of sublingual tablets of lisinopril

Formulation and evaluation of sublingual tablets of lisinopril Journal of GROVER Scientific & Industrial AGARWAL: Research FORMULATION AND EVALUATION OF SUBLINGUAL TABLETS OF LISINOPRIL Vol. 71, June 2012, pp. 413-417 413 Formulation and evaluation of sublingual tablets

More information

Formulation and Development of Sustained Release Tablets of Valsartan Sodium

Formulation and Development of Sustained Release Tablets of Valsartan Sodium INTERNATIONAL JOURNAL OF ADVANCES IN PHARMACY, BIOLOGY AND CHEMISTRY Research Article Formulation and Development of Sustained Release Tablets of Valsartan Sodium G. Sandeep * and A. Navya Department of

More information

Asian Journal of Pharmacy and Life Science ISSN Vol. 2 (2), July-Sept,2012

Asian Journal of Pharmacy and Life Science ISSN Vol. 2 (2), July-Sept,2012 STUDIES ON EFFECT OF SUPERDISINTEGRANTS ON ETORICOXIB TABLET FORMULATIONS Chowdary K. P. R 1, Venugopal. K *2 1 College of Pharmaceutical Sciences, Andhra University, Vishakapattanam. 2 * Nirmala college

More information

Formulation and Evaluation of Glicazide Mouth Dissolving Tablets

Formulation and Evaluation of Glicazide Mouth Dissolving Tablets Research Article Vishakha S. Hastak*, Yogyata S. Pathare, Kiran C. Mahajan Department of Pharmaceutics, Shree Chanakya Education Society's Indira college of Pharmacy, Tathawade, Pune, Maharashtra, India.

More information

FORMULATION AND CHARACTERIZATION OF TELMISATAN SOLID DISPERSIONS

FORMULATION AND CHARACTERIZATION OF TELMISATAN SOLID DISPERSIONS International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN : 974-434 Vol.2, No.1, pp 341-347, Jan-Mar 1 FORMULATION AND CHARACTERIZATION OF TELMISATAN SOLID DISPERSIONS Kothawade S. N. 1 *, Kadam

More information

FORMULATIO A D EVALUATIO OF ORO DISPERSIBLE TABLETS OF CLO AZEPAM BY DIRECT COMPRESSIO METHOD

FORMULATIO A D EVALUATIO OF ORO DISPERSIBLE TABLETS OF CLO AZEPAM BY DIRECT COMPRESSIO METHOD FORMULATIO A D EVALUATIO OF ORO DISPERSIBLE TABLETS OF CLO AZEPAM BY DIRECT COMPRESSIO METHOD THAKKAR HARDIK R*, A.SENTHIL, RAVIKUMAR, V.B. NARAYANA SWAMY Karavali College of Pharmacy, Mangalore-575028,

More information

Formulation And Evaluation Of Flurbiprofen Matrix Tablets For Colon Targeting

Formulation And Evaluation Of Flurbiprofen Matrix Tablets For Colon Targeting Formulation And Evaluation Of Flurbiprofen Matrix Tablets For Colon Targeting Biresh Kumar Sarkar* 1, Devananda Jain 1, Mamta Parwal 2 1. Bhagwant University, Dept.of Pharmaceutical Tech and Sciences,

More information

3.1 Background. Preformulation Studies

3.1 Background. Preformulation Studies Preformulation Studies 3.1 Background Delivery of any drug requires a suitable dosage form to get optimum therapeutic effects. The development of such dosage forms fundamental properties of the drug molecule

More information

Optimization of valsartan tablet formulation by 2 3 factorial design

Optimization of valsartan tablet formulation by 2 3 factorial design Research Article ISSN: 0974-6943 K. P. R. Chowdary et al. / Journal of Pharmacy Research 2014,8(9, Available online through http://jprsolutions.info Optimization of valsartan tablet formulation by 2 3

More information

Asian Journal of Biochemical and Pharmaceutical Research

Asian Journal of Biochemical and Pharmaceutical Research ISSN: 2231-2560 Research Article Asian Journal of Biochemical and Pharmaceutical Research Design and Evaluation of Gastroretentive Floating Tablets of Dipyridamole: Influence of Formulation Variables A.

More information

EVALUATION OF EFFERVESCENT FLOATING TABLETS. 6.7 Mathematical model fitting of obtained drug release data

EVALUATION OF EFFERVESCENT FLOATING TABLETS. 6.7 Mathematical model fitting of obtained drug release data EVALUATION OF EFFERVESCENT FLOATING TABLETS 6.1 Technological characteristics of floating tablets 6.2 Fourier transform infrared spectroscopy (FT-IR) 6.3 Differential scanning calorimetry (DSC) 6.4 In

More information

FORMULATION AND EVALUATION OF ACECLOFENAC SODIUM BILAYER SUSTAINED RELEASE TABLETS

FORMULATION AND EVALUATION OF ACECLOFENAC SODIUM BILAYER SUSTAINED RELEASE TABLETS International Journal of ChemTech Research CODEN( USA): IJCRGG ISSN : 0974-4290 Vol.1, No.4, pp 1381-1385, Oct-Dec 2009 FORMULATION AND EVALUATION OF ACECLOFENAC SODIUM BILAYER SUSTAINED RELEASE TABLETS

More information

Design and In-vitro Evaluation of Silymarin Bilayer Tablets

Design and In-vitro Evaluation of Silymarin Bilayer Tablets CODEN (USA)-IJPRUR, e-issn: 2348-6465 International Journal of Pharma Research and Health Sciences Available online at www.pharmahealthsciences.net Original Article Design and In-vitro Evaluation of Silymarin

More information

7. SUMMARY, CONCLUSION AND RECOMMENDATIONS

7. SUMMARY, CONCLUSION AND RECOMMENDATIONS 211 7. SUMMARY, CONCLUSION AND RECOMMENDATIONS Drug absorption from the gastro intestinal tract can be limited by various factors with the most common one being poor aqueous solubility and poor permeability

More information

FORMULATION AND EVALUATION OF BILAYERED TABLET OF METFORMIN HYDROCHLORIDE AND PIOGLITAZONE HYDROCHLORIDE

FORMULATION AND EVALUATION OF BILAYERED TABLET OF METFORMIN HYDROCHLORIDE AND PIOGLITAZONE HYDROCHLORIDE Academic Sciences International Journal of Pharmacy and Pharmaceutical Sciences ISSN- 975-1491 Vol 4, Suppl 5, 212 FORMULATION AND EVALUATION OF BILAYERED TABLET OF METFORMIN HYDROCHLORIDE AND PIOGLITAZONE

More information

FABRICATION AND EVALUATION OF GLIMEPIRIDE CORDIA DICHOTOMA G.FORST FRUIT MUCILAGE SUSTAINED RELEASE MATRIX TABLETS

FABRICATION AND EVALUATION OF GLIMEPIRIDE CORDIA DICHOTOMA G.FORST FRUIT MUCILAGE SUSTAINED RELEASE MATRIX TABLETS Int. J. Chem. Sci.: 7(4), 2009, 2555-2560 FABRICATION AND EVALUATION OF GLIMEPIRIDE CORDIA DICHOTOMA G.FORST FRUIT MUCILAGE SUSTAINED RELEASE MATRIX TABLETS HINDUSTAN ABDUL AHAD *, B. PRADEEP KUMAR, C.

More information

Preformulation Study. CHAPTER 3 Preformulation Study. 3.0 Introduction

Preformulation Study. CHAPTER 3 Preformulation Study. 3.0 Introduction CHAPTER 3 3.0 Introduction As per Sir Arthur Conan Doyle, It is a capital mistake to theorize before one has data. Preformulation work is the foundation for development of any robust formulations (G. Banker

More information

Formulation and Optimization of Immediate Release Tablet of Sitagliptin Phosphate using Response Surface Methodology

Formulation and Optimization of Immediate Release Tablet of Sitagliptin Phosphate using Response Surface Methodology Formulation and Optimization of Immediate Release Tablet of Sitagliptin Phosphate using Response Surface Methodology Sunita Shakya Department of Pharmacy, Kathmandu University, Kavre, Nepal. Email: sunita95@gmail.com

More information

PREPARATION AND EVALUATION OF STARCH - PEG 1500 CO-PROCESSED EXCIPIENT AS A NEW DIRECTLY COMPRESSIBLE VEHICLE IN TABLET FORMULATIONS

PREPARATION AND EVALUATION OF STARCH - PEG 1500 CO-PROCESSED EXCIPIENT AS A NEW DIRECTLY COMPRESSIBLE VEHICLE IN TABLET FORMULATIONS INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY Available online at www.ijrpc.com Research Article PREPARATION AND EVALUATION OF STARCH - PEG 1500 CO-PROCESSED EXCIPIENT AS A NEW DIRECTLY COMPRESSIBLE

More information

xvi LIST OF TABLES S.NO Title of the Table Page No 2.1 Composition of zolmitriptan formulations Powder flow properties and angle of repose 58

xvi LIST OF TABLES S.NO Title of the Table Page No 2.1 Composition of zolmitriptan formulations Powder flow properties and angle of repose 58 xvi LIST OF TABLES S.NO Title of the Table Page No CHAPTER 2 2.1 Composition of zolmitriptan formulations 55 2.2 Powder flow properties and angle of repose 58 2.3 Uniformity of weight 59 2.4 Calibration

More information

FORMULATION AND EVALUATION OF CEFIXIME TRIHYDRATE ORAL DISINTEGRATING AGENTS

FORMULATION AND EVALUATION OF CEFIXIME TRIHYDRATE ORAL DISINTEGRATING AGENTS Academic Sciences International Journal of Pharmacy and Pharmaceutical Sciences ISSN- 0975-1491 Vol 4, Suppl 1, 2012 Research Article FORMULATION AND EVALUATION OF CEFIXIME TRIHYDRATE ORAL DISINTEGRATING

More information

Available online Research Article

Available online   Research Article Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 26, 8(2):7-7 Research Article ISSN : 975-7384 CODEN(USA) : JCPRC5 Optimization of directly compressible mixtures of microcrystalline

More information

Int. Res J Pharm. App Sci., 2014; 4(1):47-51 ISSN:

Int. Res J Pharm. App Sci., 2014; 4(1):47-51 ISSN: International Research Journal of Pharmaceutical and Applied Sciences (IRJPAS) Available online at www.irjpas.com Int. Res J Pharm. App Sci., 2014; 4(1):47-51 Research Article FORMULATION AND EVALUATION

More information

Design and Characterization of Valsartan Loaded Press Coated Pulsatile Tablets

Design and Characterization of Valsartan Loaded Press Coated Pulsatile Tablets Research Reviews: Pharmacy & Pharmaceutical Sciences e-issn: 2320-1215 www.rroij.com Design and Characterization of Valsartan Loaded Press Coated Pulsatile Tablets Sowjanya Battu*, Madhavi K, Bhikshapathi

More information

FORMULATION AND EVALUATION OF BISOPROLOL FUMARATE FAST DISSOLVING TABLET BY DIRECT COMPRESSION TECHNIQUES

FORMULATION AND EVALUATION OF BISOPROLOL FUMARATE FAST DISSOLVING TABLET BY DIRECT COMPRESSION TECHNIQUES Research Article Deshmukh ND,, 2012; Volume 1(5): 364-378 ISSN: 2277-8713 FORMULATION AND EVALUATION OF BISOPROLOL FUMARATE FAST DISSOLVING TABLET BY DIRECT COMPRESSION TECHNIQUES *N. D. DESHMUKH, R. R.

More information

Research Journal of Pharmaceutical, Biological and Chemical Sciences

Research Journal of Pharmaceutical, Biological and Chemical Sciences Research Journal of Pharmaceutical, Biological and Chemical Sciences Formulation And Invitro Evaluation Of Sustained Release Matrix Tablets Of Ibuprofen S Shanmugam, T Vetrichelvan and P Niranjan* Adhiparasakthi

More information

Design and development of fast Melting Tablets of Terbutaline Sulphate

Design and development of fast Melting Tablets of Terbutaline Sulphate Design and development of fast Melting Tablets of Terbutaline Sulphate Mathew T and Agrawal S Swami Vivekanand College of Pharmacy, Khandwa Road, Indore (MP), INDIA Available online at: www.isca.in (Received

More information

The purpose of the present investigation was to design a formulation of orodispersible tablets of Etoricoxib by adopting

The purpose of the present investigation was to design a formulation of orodispersible tablets of Etoricoxib by adopting Research ARTICLE Formulation design and optimization of orodispersible tablets of etoricoxib by response surface methodology S R Shahi, G R Agrawal, N V Shinde, S A Shaikh 1, S S Shaikh, A N Padalkar 3,

More information

Formulation Development, Evaluation and Comparative Study of Effects of Super Disintegrants in Cefixime Oral Disintegrating Tablets

Formulation Development, Evaluation and Comparative Study of Effects of Super Disintegrants in Cefixime Oral Disintegrating Tablets Pharmaceutics Formulation Development, Evaluation and Comparative Study of Effects of Super Disintegrants in Cefixime Oral Disintegrating Tablets Remya KS, Beena P, Bijesh PV, Sheeba A Nazareth College

More information

Formulation, Optimization and Evaluation of Mouth Dissolving Tablet of Zidovudine

Formulation, Optimization and Evaluation of Mouth Dissolving Tablet of Zidovudine Formulation, Optimization and Evaluation of Mouth Dissolving Tablet of Zidovudine Mayur V. Chinchore*, Sanjay P. Aher, Chetan P. Mahajan, Ghanshyam J. Yadav, Avish D. Maru Department of Pharmaceutics,

More information

Formulation and evaluation of mouth dissolving tablets containing losartan potassium

Formulation and evaluation of mouth dissolving tablets containing losartan potassium Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2016, 8 (17):115-123 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4

More information

Formulation and evaluation of intraorally fast dissolving tablet of olmesartan medoxomil

Formulation and evaluation of intraorally fast dissolving tablet of olmesartan medoxomil Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2013, 5 (1):232-237 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4

More information

Available online through ISSN

Available online through  ISSN Research Article Available online through www.ijrap.net ISSN 2229-3566 FORMULATION AND EVALUATION OF ORO DISPERSIBLE TABLETS OF METOPROLOL TARTRATE BY DIRECT COMPRESSION USING SUPER DISINTEGRANTS A. Senthil*

More information

Formulation Development of Aceclofenac Tablets Employing Starch Phosphate -A New Modified Starch

Formulation Development of Aceclofenac Tablets Employing Starch Phosphate -A New Modified Starch Abstract K.P.R. Chowdary et al. / International Journal of Pharma Sciences and Research (IJPSR) Formulation Development of Aceclofenac Tablets Employing Starch Phosphate -A New Modified Starch K.P.R. Chowdary*,

More information

Volume: 2: Issue-3: July-Sept ISSN FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF NICORANDIL

Volume: 2: Issue-3: July-Sept ISSN FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF NICORANDIL Volume: 2: Issue-3: July-Sept -2011 ISSN 0976-4550 FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF NICORANDIL Ajaykumar Patil*, Ashish Pohane, Ramya Darbar, Sharanya Koutika, Alekhya

More information

May Vol: 06 Issue: 01 (1-12)

May Vol: 06 Issue: 01 (1-12) May 16 Vol: 6 Issue: 1 (1-1) RESEARCH PAPER Formulation and Evaluation of Extended Release Tablets of Metformin HCl Anamika Chouhan*1, Deepak Marothia1, Khushboo Ranka1, Kamal Singh Rathore 1Department

More information

A FACTORIAL STUDY ON THE ENHANCEMENT OF DISSOLUTION RATE OF KETOPROFEN BY SOLID DISPERSION IN COMBINED CARRIERS

A FACTORIAL STUDY ON THE ENHANCEMENT OF DISSOLUTION RATE OF KETOPROFEN BY SOLID DISPERSION IN COMBINED CARRIERS Research Article A FACTORIAL STUDY ON THE ENHANCEMENT OF DISSOLUTION RATE OF KETOPROFEN BY SOLID DISPERSION IN COMBINED CARRIERS K. P. R. Chowdary *, Tanniru Adinarayana, T. Vijay, Mercy. R. Prabhakhar

More information

Pharmacologyonline 2: (2011) ewsletter Mehul et al. FORMULATIO A D EVALUATIO OF ORODISPERSIBLE TABLETS OF PHE IRAMI E MALEATE

Pharmacologyonline 2: (2011) ewsletter Mehul et al. FORMULATIO A D EVALUATIO OF ORODISPERSIBLE TABLETS OF PHE IRAMI E MALEATE FORMULATIO A D EVALUATIO OF ORODISPERSIBLE TABLETS OF PHE IRAMI E MALEATE DAVE MEHUL *, A.SENTHIL, THAKKAR HARDIK R, RAVIKUMAR, LAD TEJAS Karavali College of Pharmacy, Mangalore-575028, Karnataka, India.

More information

Study of Disintegrant Property of Moringa Oleifera Gum and its Comparison with other Superdisintegrants

Study of Disintegrant Property of Moringa Oleifera Gum and its Comparison with other Superdisintegrants International Journal of ChemTech Research CODEN( USA): IJCRGG ISSN : 0974-4290 Vol. 3, No.3, pp 1119-1124, July-Sept 2011 Study of Disintegrant Property of Moringa Oleifera Gum and its Comparison with

More information

Formulation Development and Evaluation of Atorvastatin Calcium Tablets using Co-Processed Excipients

Formulation Development and Evaluation of Atorvastatin Calcium Tablets using Co-Processed Excipients Int. J. Pharm. Sci. Rev. Res., 36(1), January February 2016; Article No. 39, Pages: 217222 Research Article Formulation Development and Evaluation of Atorvastatin Calcium Tablets using CoProcessed Excipients

More information

FORMULATION AND EVALUATION OF VALSARTAN TABLETS EMPLOYING CYCLODEXTRIN-POLOXAMER 407-PVP K30 INCLUSION COMPLEXES

FORMULATION AND EVALUATION OF VALSARTAN TABLETS EMPLOYING CYCLODEXTRIN-POLOXAMER 407-PVP K30 INCLUSION COMPLEXES Int. J. Chem. Sci.: 10(1), 2012, 297-305 ISSN 0972-768X www.sadgurupublications.com FORMULATION AND EVALUATION OF VALSARTAN TABLETS EMPLOYING CYCLODEXTRIN-POLOXAMER 407-PVP K30 INCLUSION COMPLEXES K. P.

More information

A Comparative Evaluation of Cross Linked Starch Urea-A New Polymer and Other Known Polymers for Controlled Release of Diclofenac

A Comparative Evaluation of Cross Linked Starch Urea-A New Polymer and Other Known Polymers for Controlled Release of Diclofenac Asian Journal of Chemistry Vol. 22, No. 6 (2010), 4239-4244 A Comparative Evaluation of Cross Linked Starch Urea-A New Polymer and Other Known Polymers for Controlled Release of Diclofenac K.P.R. CHOWDARY*

More information

Formulation and In-vitro Evaluation of Sumatriptan succinate Bilayer Tablets

Formulation and In-vitro Evaluation of Sumatriptan succinate Bilayer Tablets Formulation and In-vitro Evaluation of Sumatriptan succinate Bilayer Tablets M. Sunitha Reddy 1, B. Sharath Reddy 1, S. Muhammed Fazal Ul Haq 1 Centre of Pharmaceutical Sciences, Jawaharlal Nehru Technological

More information

MEDAK DIST. ANDHRA PRADESH STATE, INDIA. Research Article RECEIVED ON ACCEPTED ON

MEDAK DIST. ANDHRA PRADESH STATE, INDIA. Research Article RECEIVED ON ACCEPTED ON Page67 Available Online through IJPBS Volume 1 Issue 2 APRIL- JUNE 2011 SIMPLE QUANTITATIVE METHOD DEVELOPMENT AND VALIDATION OF VALSARTAN IN PUREFORM AND PHARMACEUTICAL DOSAGE FORMS BYUV SPECTROSCOPY

More information

Asian Journal of Research in Biological and Pharmaceutical Sciences Journal home page:

Asian Journal of Research in Biological and Pharmaceutical Sciences Journal home page: Research Article ISSN: 2349 4492 Asian Journal of Research in Biological and Pharmaceutical Sciences Journal home page: www.ajrbps.com DESIGN, DEVELOPMENT AND EVALUATION OF PULSATILE DRUG DELIVERY SYSTEM

More information

Formulation and evaluation of Orodispersible tablets to enhance dissolution rate of Lamotrigine by using Solid Dispersion Technique

Formulation and evaluation of Orodispersible tablets to enhance dissolution rate of Lamotrigine by using Solid Dispersion Technique 35 Formulation and evaluation of Orodispersible tablets to enhance dissolution rate of Lamotrigine by using Solid Dispersion Technique Bhumi B. Patel 1 *, Chainesh N. Shah 2, Rumit M. Shah 3 1 Department

More information

Formulation Development and Evaluation of Bilayer Floating Tablet of Antidiabetic Drugs

Formulation Development and Evaluation of Bilayer Floating Tablet of Antidiabetic Drugs Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 0, 8 ():- (http://scholarsresearchlibrary.com/archive.html) ISSN 097-07 USA CODEN: DPLEB Formulation

More information

FORMULATION AND EVALUATION OF MELT-IN-MOUTH TABLETS OF DOMPERIDONE CONTAINING MULTICOMPONENT INCLUSION COMPLEX

FORMULATION AND EVALUATION OF MELT-IN-MOUTH TABLETS OF DOMPERIDONE CONTAINING MULTICOMPONENT INCLUSION COMPLEX Academic Sciences International Journal of Pharmacy and Pharmaceutical Sciences ISSN- 0975-1491 Vol 4, Issue 1, 2012 Research Article FORMULATION AND EVALUATION OF MELT-IN-MOUTH TABLETS OF DOMPERIDONE

More information

DESIGN, DEVELOPMENT AND OPTIMIZATION OF FAST DISSOLVING TABLET OF NEBIVOLOL HCL

DESIGN, DEVELOPMENT AND OPTIMIZATION OF FAST DISSOLVING TABLET OF NEBIVOLOL HCL DESIGN, DEVELOPMENT AND OPTIMIZATION OF FAST DISSOLVING TABLET OF NEBIVOLOL HCL Isha Shah, Alpesh Yadav, Shailendra Bhatt Maharishi Arvind Institute of Pharmacy, Mansarovar, Jaipur, India-3000. Abstract

More information

Asian Journal of Research in Biological and Pharmaceutical Sciences

Asian Journal of Research in Biological and Pharmaceutical Sciences Research Article ISSN: 2349 4492 Asian Journal of Research in Biological and Pharmaceutical Sciences Journal home page: www.ajrbps.com APPLICATION OF FACTORIAL DESIGN AND OPTIMIZATION OF GLIMEPIRIDE SUSTAINED

More information

FORMULATION AND EVALUATION OF FLOATING TABLETS OF NORFLOXACIN

FORMULATION AND EVALUATION OF FLOATING TABLETS OF NORFLOXACIN FORMULATION AND EVALUATION OF FLOATING TABLETS OF NORFLOXACIN Ms. Jyoti Rathore 1*, Mr. Hitesh Kumar Parmar 1 Ujjain Institute of Pharmaceutical Sciences, Ujjain. Email- hkparmar7@rediffmail.com ABSTRACT

More information

Adimoolam Senthil et al. IRJP 2 (1)

Adimoolam Senthil et al. IRJP 2 (1) INTERNATIONAL RESEARCH JOURNAL OF PHARMACY ISSN 2230 8407 Available online http://www.irjponline.com Research Article DEVELOPMENT AND EVALUATION OF ORALLY DISINTEGRATING TABLETS OF METOPROLOL TARTRATE

More information

DEVELOPMENT OF NON SODIUM EFFERVESCENT TABLET OF PARACETAMOL USING ARGININE CARBONATE

DEVELOPMENT OF NON SODIUM EFFERVESCENT TABLET OF PARACETAMOL USING ARGININE CARBONATE IJPSR (2013), Vol. 4, Issue 5 (Research Article) Received on 17 July, 2012; received in revised form, 23 February, 2013; accepted, 14 April, 2013 DEVELOPMENT OF NON SODIUM EFFERVESCENT TABLET OF PARACETAMOL

More information

Venkateswara Rao et.al Indian Journal of Research in Pharmacy and Biotechnology ISSN: (Print) ISSN: (Online)

Venkateswara Rao et.al Indian Journal of Research in Pharmacy and Biotechnology ISSN: (Print) ISSN: (Online) Design and development of Metformin hydrochloride Tried sustained release tablets Venkateswara Rao T 1 *, Bhadramma N 1, Raghukiran CVS 2 and Madubabu K 3 Bapatla College of Pharmacy, Bapatla, Guntur-522101

More information

Journal of Global Trends in Pharmaceutical Sciences

Journal of Global Trends in Pharmaceutical Sciences An Elsevier Indexed Journal ISSN-2230-7346 Journal of Global Trends in Pharmaceutical Sciences FORMULATION AND CHARACTERIZATION OF ORAL DISINTEGRATING TABLETS OF VALSARTAN BY SUBLIMATION AND EFFERVESCENCE

More information

EFFECT OF SUPERDISINTEGRANTS ON RELEASE OF DOMPERIDONE FROM FAST DISSOLVING TABLETS

EFFECT OF SUPERDISINTEGRANTS ON RELEASE OF DOMPERIDONE FROM FAST DISSOLVING TABLETS ISSN: 22-7346 B. Sujatha et al. / JGTPS/ 5(3)-(2014) 1973 1978 (Research Article) Journal of Global Trends in Pharmaceutical Sciences Journal home page: www.jgtps.com EFFECT OF SUPERDISINTEGRANTS ON RELEASE

More information

Formulation and Evaluation of Oral disintegrated tablets of Alfuzosin Hydrochloride using superdisintegrants

Formulation and Evaluation of Oral disintegrated tablets of Alfuzosin Hydrochloride using superdisintegrants ISSN: 2231-3354 Received on: 13-11-2011 Revised on: 18:11:2011 Accepted on: 22-11-2011 Formulation and Evaluation of Oral disintegrated tablets of Alfuzosin Hydrochloride using superdisintegrants Leela

More information

Preparation and Evaluation of Silymarin Controlled Release Tablets Prepared Using Natural Gums

Preparation and Evaluation of Silymarin Controlled Release Tablets Prepared Using Natural Gums 1368 International Journal of Pharmaceutical Sciences and Nanotechnology Volume 4 Issue 1 April-June 211 Research Paper International Journal of Pharmaceutical Sciences and Nanotechnology Volume 4 Issue

More information

Research Article Derivative Spectrophotometric Method for Estimation of Metformin Hydrochloride in Bulk Drug and Dosage Form

Research Article Derivative Spectrophotometric Method for Estimation of Metformin Hydrochloride in Bulk Drug and Dosage Form Research Article Derivative Spectrophotometric Method for Estimation of Metformin Hydrochloride in Bulk Drug and Dosage Form Gowekar NM, Lawande YS*, Jadhav DP, Hase RS and Savita N. Gowekar Department

More information

DESIGN AND CHARACTERIZATION OF FLOATING TABLETS OF ANTI-DIABETIC DRUG

DESIGN AND CHARACTERIZATION OF FLOATING TABLETS OF ANTI-DIABETIC DRUG INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY Available online at www.ijrpc.com Research Article DESIGN AND CHARACTERIZATION OF FLOATING TABLETS OF ANTI-DIABETIC DRUG M Seth *, DS Goswami,

More information

Int. J. Pharm. Sci. Rev. Res., 28(1), September October 2014; Article No. 21, Pages:

Int. J. Pharm. Sci. Rev. Res., 28(1), September October 2014; Article No. 21, Pages: Research Article V.T. Iswariya 1 *, A Hariom Prakash Rao 1, V Lokeswara Babu 1, Mohd Abdul Hadi 1, A Srinivasa Rao 2 1 Dept. of Pharmaceutics, Bhaskar Pharmacy College, Bhaskar Nagar, Yenkapally (V), Moinabad

More information

Maisammaguda, Dulapally, Secundrabad.

Maisammaguda, Dulapally, Secundrabad. 121 P a g e International Standard Serial Number (ISSN): 2319-8141 International Journal of Universal Pharmacy and Bio Sciences 3(6): November-December 2014 INTERNATIONAL JOURNAL OF UNIVERSAL PHARMACY

More information

Formulation and evaluation of oral dispersible tablets of aripiprazole

Formulation and evaluation of oral dispersible tablets of aripiprazole IJPAR Vol.6 Issue 2 April - June -17 Journal Home page: ISSN:23-2831 Research article Open Access Formulation and evaluation of oral dispersible tablets of aripiprazole A.Madhusudhan Reddy*, P.Srinivasababu,

More information

The present study deals with the formulation of fast dissolving tablets of poorly soluble carbamazepine by the direct

The present study deals with the formulation of fast dissolving tablets of poorly soluble carbamazepine by the direct Research ARTICLE Development and evaluation of carbamazepine fast dissolving tablets prepared with a complex by direct compression technique N G Raghavendra Rao, T Patel 1, S Gandhi 1 Department of Pharmaceutics,

More information

Feasibility of using natural gums for development of sustained release matrix tablet of itopride

Feasibility of using natural gums for development of sustained release matrix tablet of itopride Available online at wwwscholarsresearchlibrarycom Scholars Research Library Der Pharmacia Lettre, 215, 7 (3):114-123 (http://scholarsresearchlibrarycom/archivehtml) ISSN 975-571 USA CODEN: DPLEB4 Feasibility

More information

Hypertension or high blood pressure (BP)

Hypertension or high blood pressure (BP) ORIGINAL ARTICLE Formulation and Evaluation of Immediate Release Telmisartan Tablets using Hydrophilic Polymers S. Swati, N. Jyothi, P. Manjusha, N. Lakshmi Prasanthi, B. Thireesha Department of Pharmaceutics,

More information

Pavan K et al IJARPB: 2013, 3(2), ISSN: Available online on Research Article

Pavan K et al IJARPB: 2013, 3(2), ISSN: Available online on  Research Article Available online on www.ijarpb.com Research Article Received on 15/01/2013; Revised on 23/01/2013; Accepted on 27/01/2013; Fast Dissolving Tablets Of Pioglitazone Hydrochloride By Use Of Various Superdisintegrants

More information

FORMULATION AND EVALUATIONOF AMOXYCILLIN: THREE-LAYER GUAR GUM MATRIX TABLET

FORMULATION AND EVALUATIONOF AMOXYCILLIN: THREE-LAYER GUAR GUM MATRIX TABLET Gupta and Singh, IJPSR, 2013; Vol. 4(7): 2683-2690. ISSN: 0975-8232 IJPSR (2013), Vol. 4, Issue 7 (Research Article) Received on 05 March, 2013; received in revised form, 29 April, 2013; accepted, 29 June,

More information

COMPARATIVE EFFECT OF DIFFERENT HIGH FUNCTIONALITY EXCIPIENTS ON VARIOUS CHARACTERISTICS OF VARDENAFIL HCL TABLETS (BCS II DRUG)

COMPARATIVE EFFECT OF DIFFERENT HIGH FUNCTIONALITY EXCIPIENTS ON VARIOUS CHARACTERISTICS OF VARDENAFIL HCL TABLETS (BCS II DRUG) IJPSR (2014), Vol. 5, Issue 12 (Research Article) Received on 27 April, 2014; received in revised form, 28 July, 2014; accepted, 08 August, 2014; published 01 December, 2014 COMPARATIVE EFFECT OF DIFFERENT

More information

Journal of Pharmaceutical and Scientific Innovation

Journal of Pharmaceutical and Scientific Innovation Journal of Pharmaceutical and Scientific Innovation www.jpsionline.com (ISSN : 2277 4572) Research Article ASSESSING THE BEST POLY VINYL PYRROLIDONE AS A CARRIER FOR ETORICOXIB SOLID DISPERSIONS: FABRICATION

More information

Research Paper The Effect of Different Superdisintegrants and their Concentrations on the Dissolution of Topiramate Immediate Release Tablets

Research Paper The Effect of Different Superdisintegrants and their Concentrations on the Dissolution of Topiramate Immediate Release Tablets International Journal of Pharmaceutical Sciences and Nanotechnology Volume 2 Issue 2 July September 2009 Research Paper The Effect of Different Superdisintegrants and their Concentrations on the Dissolution

More information

Development and evaluation of controlled release mucoadhesive tablets of Tramadol Hydrochloride

Development and evaluation of controlled release mucoadhesive tablets of Tramadol Hydrochloride Development and evaluation of controlled release mucoadhesive tablets of Tramadol Hydrochloride R. Margret Chandira*, C.M. Sahu and B. Jayakar Department of Pharmaceutics Vinayaka Mission s College of

More information

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY ISSN Research Article

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY  ISSN Research Article INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 8407 Research Article FORMULATION AND EVALUATION OF PRAVASTATIN SODIUM IMMEDIATE RELEASE TABLETS Devanand Pinate 1 *, Ravikumar 1,

More information

Karnataka Department of Pharmaceutical Technology, H.K.E. Society s College of Pharmacy, Gulbarga, Karnataka ABSTRACT KEYWORDS:

Karnataka Department of Pharmaceutical Technology, H.K.E. Society s College of Pharmacy, Gulbarga, Karnataka ABSTRACT KEYWORDS: 335 P a g e International Standard Serial Number (ISSN): 2319-8141 International Journal of Universal Pharmacy and Bio Sciences 4(6): November-December 2015 INTERNATIONAL JOURNAL OF UNIVERSAL PHARMACY

More information

IJRPC 2011, 1(4) Rohan et al. ISSN: INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY

IJRPC 2011, 1(4) Rohan et al. ISSN: INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY Available online at www.ijrpc.com Research Article ABSORPTION CORRECTION METHOD AND SIMULTANEOUS EQUATION METHOD FOR THE SIMULTANEOUS ESTIMATION

More information

RESEARCH ARTICLE. Darshanwar Varun.S.*,Jadhav S.B. Hambarde. S.K.

RESEARCH ARTICLE. Darshanwar Varun.S.*,Jadhav S.B. Hambarde. S.K. RESEARCH ARTICLE ISSN: 2348-8948 Vol: 3; Issue: 7 DEVELOPMENT AND EVALUATION OF PULSATILE DRUG DELIVERY SYSTEM OF DILTIAZEM HYDROCHLORIDE Darshanwar Varun.S.*,Jadhav S.B. Hambarde. S.K. Department of Pharmaceutics,

More information

Available Online through

Available Online through ISSN: 0975-766X Available Online through Research Article www.ijptonline.com FORMULATION DESIGN AND OPTIMIZATION OF MOUTH DISSOLVE TABLETS OF GLIPIZIDE R.Shireesh Kiran 1*, B.Chander Shekar 1, Sharadha

More information

Available Online through Research Article

Available Online through Research Article ISSN: 0975-766X Available Online through Research Article www.ijptonline.com DESIGN AND EVALUATION OF GASTRORETENTIVE TABLETS FOR CONTROLLED DELIVERY OF NORFLOXOCIN Ganesh Kumar Gudas*, Subal Debnath,

More information

Formulation Development and Evaluation of Antidiabetic Polyherbal Tablet

Formulation Development and Evaluation of Antidiabetic Polyherbal Tablet Research Article Formulation Development and Evaluation of Antidiabetic Polyherbal Tablet Komal Patel 1*, Lal Hingorani 2, Vinit Jain 3 1 School of Pharmacy, RK University, Rajkot and Parul Institute of

More information

FORMULATION DEVELOPMENT AND EVALUATION OF COLON TARGETED DOSAGE FORM OF IBUPROFEN

FORMULATION DEVELOPMENT AND EVALUATION OF COLON TARGETED DOSAGE FORM OF IBUPROFEN FORMULATION DEVELOPMENT AND EVALUATION OF COLON TARGETED DOSAGE FORM OF IBUPROFEN Pranjal Kumar Singh*, Sanjoo Kumar, T.S.Easwari, V.K.Shukla, Guru Sharan Department of Pharmaceutics, IIMT College of Medical

More information

Journal of Chemical and Pharmaceutical Research

Journal of Chemical and Pharmaceutical Research Available on line www.jocpr.com Journal of Chemical and Pharmaceutical Research J. Chem. Pharm. Res., 2010, 2(5):534-540 ISSN No: 0975-7384 CODEN(USA): JCPRC5 Formulation and evaluation of Valsartan film

More information

DEVELOPMENT AND EVALUATION OF A DIRECTLY COMPRESSIBLE CO PROCESSED MULTIFUNCTION SUSTAINED RELEASE AGENT FOR TABLETS

DEVELOPMENT AND EVALUATION OF A DIRECTLY COMPRESSIBLE CO PROCESSED MULTIFUNCTION SUSTAINED RELEASE AGENT FOR TABLETS International Journal of Pharmacy and Pharmaceutical Sciences ISSN- 975-1491 Vol 2, Suppl 4, 1 Research Article DEVELOPMENT AND EVALUATION OF A DIRECTLY COMPRESSIBLE CO PROCESSED MULTIFUNCTION SUSTAINED

More information

DESIGN AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF FLURBIPROFEN

DESIGN AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF FLURBIPROFEN Int. J. Chem. Sci.: 10(4), 2012, 2199-2208 ISSN 0972-768X www.sadgurupublications.com DESIGN AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF FLURBIPROFEN K. V. R. N. S. RAMESH *, B. HEMA KIRNAMAYI

More information

Global College of Pharmacy, Kahnpur Khui, Tehsil Anandpur Sahib, Distt.- Ropar, Punjab, India

Global College of Pharmacy, Kahnpur Khui, Tehsil Anandpur Sahib, Distt.- Ropar, Punjab, India IJPSR (2012), Vol. 3, Issue 09 (Research Article) Received on 19 May, 2012; received in revised form 25 June, 2012; accepted 27 August, 2012 IN-VITRO EVALUATION OF TWO MARKETED BRANDS OF PARACETAMOL TABLETS

More information

Patel B et al. IRJP 1 (1)

Patel B et al. IRJP 1 (1) INTERNATIONAL RESEARCH JOURNAL OF PHARMACY Available online http://www.irjponline.com Research Article IMPROVEMENT OF SOLUBILITY OF CINNARIZINE BY USING SOLID DISPERSION TECHNIQUE Patel Bipin*, Patel Jayvadan,

More information

Research Journal of Pharmaceutical, Biological and Chemical Sciences

Research Journal of Pharmaceutical, Biological and Chemical Sciences Research Journal of Pharmaceutical, Biological and Chemical Sciences Development and characterisation of oral fast dissolving tablet of nifedipine using camphor as a subliming material Shinde Anilkumar

More information

Formulation and evaluation of sustained release atenolol

Formulation and evaluation of sustained release atenolol 9 Formulation, optimization and evaluation of sustained release layer of atenolol Atenolol is a cardioselective β-blocker widely prescribed for asymptomatic condition such as hypertension. It is poorly

More information

Design and evaluation of immediate release tablets of divalproex sodium

Design and evaluation of immediate release tablets of divalproex sodium Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2015, 7 (5):87-92 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4

More information

Adimoolam S et al. IRJP 1 (1)

Adimoolam S et al. IRJP 1 (1) INTERNATIONAL RESEARCH JOURNAL OF PHARMACY Available online http://www.irjponline.com Research Article FORMULATION AND EVALUATION OF MOUTH DISSOLVING TABLETS OF FLUNARIZINE DIHYDROCHLORIDE BY USING SUPER

More information